No Detail Found!

Characteristics and Outcomes in Patients with Anti N-methyl-d- Aspartate Receptor Auto-immune Encephalitis.

Author(s)
Syed Onaiz Zulfiqar Anwar Combined Military Hospital Multan, Pakistan
Jahanzeb Liaqat Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Waseem Alamgir Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Abstract
Objective: To study characteristics and outcome in patients with anti-N-Methyl-D-Aspartic Receptor encephalitis. Study Design: Retrospective observational cohort. Place and Duration of Study: Neurology Department Military Hospital Rawalpindi, from Feb 2015 to Sep 2016. Material and Methods: Data of patients admitted with anti-n-methyl-D-aspartate receptor encephalitis was analyzed retrospectively. Patients were classified as having definite or probable anti-N-methyl-D-sspartate receptor encephalitis whether antibody testing in CSF was positive or negative respectively and fulfillment of other defined parameters. Patient characteristics, treatment protocols and outcomes were noted. Results: Eleven patients were included in this cohort. Six (54.5%) were males and 5 (45.5%) were female. Mean age was 31.18 years (SD 14.865). Mean day to symptom onset was 18.51 days (SD 16.646). Abnormal behavior was seen in 90.9%, Seizures and movement disorder in 81.8%, speech dysfunction in 72.7%, decreased level of consciousness in 63.6% and autonomic dysfunction in 54.5% anti-N-methyl-D-aspartate receptor antibodies were done in CSF in 3 patients only out of which 2 were positive. In remaining nine patients antibody testing was not done due non availability of facility and or affordability. Out of eleven patients 2 (18.25%) had definite encephalitis and 7 (81.8%) had probable encephalitis. CSF was abnormal in 63.6% with pleocytosis in 18.2% and oligoclonal bands in 45.5%. EEG was abnormal in 72.7% and MRI was annormal in 36.4%. Outcome was favorable in 63.6% and unfavorable in 36.4%. Conclusion: In this study we were able to determine that patients with anti-N-Methyl-D-Aspartate Receptor encephalitis have a favorable outcome if diagnosed and treated aggressively early in the course of disease.
Publication Details
Page(s) 202-206
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 2, Year: 2018

Request the full text from PASTIC

References
DalmauJ,TüzünE,WuHY,MasjuanJ,RossiJE,VoloschinA, 2007.Paraneoplastic anti-N-methyl-D-aspartate receptor encepha-litis associated with ovarian teratoma,Ann Neurol 61 25 -36
GableMS,SheriffH,DalmauJ,TilleyDH, 2012.The frequency of autoimmune N-methyl-Daspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project,Clin Infect Dis 54 899 -904
TitulaerMJ,McCrackenL,GabilondoI,ArmanguéT,GlaserC,IizukaT, 2013.Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study,Lancet Neurol 12 157 -65
VenkatesanA,TunkelAR,BlochKC,LauringAS,SejvarJ,BitnunA, 2013.Case defi nitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium,Clin Infect Dis 57 1114 -28
BallR,HalseyN,BraunMM,MoultonLH,GaleAD,RammohanK, 2002.Development of case definitions for acute encepha-lopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System,J Clin Epidemiol 55 819 -24
BrittonPN,EastwoodK,PatersonB,DurrheimDN,DaleRC,ChengAC, 2015.Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand,Intern Med J 45 563 -76
LeypoldtF,ArmangueT,DalmauJ,Autoimmune, 2015.,Ann N Y Acad Sci 1338 94 -114
GranerodJ,AmbroseHE,DaviesNW,ClewleyJP,WalshAL,MorganD, 2010.Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study,Lancet Infect Dis 10 835 -44
DalmauJ,LancasterE,Martinez-HernandezE,RosenfeldMR,BaliceGordonR., 2011.Clinical experience and laboratory investi-gations in patients with anti-NMDAR encephalitis,Lancet Neurol 10 63 -74
DalmauJ,GleichmanAJ,HughesEG,RossiJE,PengX,LaiM, 2008.AntiNMDA-receptor encephalitis: Case series and analysis of the eff ects of antibodies,Lancet Neurol 7 1091 -98
TitulaerMJ,McCrackenL,GabilondoI,ArmanguéT,GlaserC,IizukaT, 2013.Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study,Lancet Neurol 12 157 -65
BarryH,HardimanO,HealyDG,KeoganM,MoroneyJ,MolnarPP, 2011.Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis,Br J Psychiatry 199 508 -9
DalmauJ,TuzunE,WuHY,MasjuanJ,RossiJE,VoloschinA, 2007.Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma,Ann Neurol 61 25 -36
FloranceNR,DavisRL,LamC,SzperkaC,ZhouL,AhmadS, 2009.AntiN-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents,Ann Neurol 66 11 -8
Gresa-ArribasN,TitulaerMJ,TorrentsA,AguilarE,McCrackenL,LeypoldtF, 2014.Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: A retrospective study,Lancet Neurol 13 167 -77
FinkeC,KoppUA,PrussH,DalmauJ,WandingerKP,PlonerCJ, 2012.Cognitive deficits following anti-NMDA receptor encephalitis,J Neurol Neurosurg Psychiatry 83 195 -8
GrausF,TitulaerMJ,BaluR,BenselerS,BienCG,CellucciT, 2016.A clinical approach to diagnosis of autoimmune encephalitis,Lancet Neurol 15 391 -404
0

Citations

0

Downloads

90

Views